EZH2 and acute myeloid leukemia: Results displayed that the EZH2 expression is significantly elevated (p < 0.0001) (Figure 5A), while PIK3IP1 is concomitantly reduced (p < 0.0001) (Figure 5B) in 88 newly diagnosed patients with AML compared to the 70 healthy controls.